Next Article in Journal
Drugs of Abuse and Their Impact on Viral Pathogenesis
Previous Article in Journal
Changes of Host Immunity Mediated by IFN-γ+ CD8+ T Cells in Children with Adenovirus Pneumonia in Different Severity of Illness
Article

A Routine Sanger Sequencing Target Specific Mutation Assay for SARS-CoV-2 Variants of Concern and Interest

Affiliation Milford Molecular Diagnostics Laboratory, 2044 Bridgeport Avenue, Milford, CT 06460, USA
Academic Editor: Donald Seto
Viruses 2021, 13(12), 2386; https://doi.org/10.3390/v13122386
Received: 31 October 2021 / Revised: 23 November 2021 / Accepted: 26 November 2021 / Published: 29 November 2021
(This article belongs to the Topic Burden of COVID-19 in Different Countries)
As SARS-CoV-2 continues to spread among human populations, genetic changes occur and accumulate in the circulating virus. Some of these genetic changes have caused amino acid mutations, including deletions, which may have a potential impact on critical SARS-CoV-2 countermeasures, including vaccines, therapeutics, and diagnostics. Considerable efforts have been made to categorize the amino acid mutations of the angiotensin-converting enzyme 2 (ACE2) receptor binding domain (RBD) of the spike (S) protein, along with certain mutations in other regions within the S protein as specific variants, in an attempt to study the relationship between these mutations and the biological behavior of the virus. However, the currently used whole genome sequencing surveillance technologies can test only a small fraction of the positive specimens with high viral loads and often generate uncertainties in nucleic acid sequencing that needs additional verification for precision determination of mutations. This article introduces a generic protocol to routinely sequence a 437-bp nested RT-PCR cDNA amplicon of the ACE2 RBD and a 490-bp nested RT-PCR cDNA amplicon of the N-terminal domain (NTD) of the S gene for detection of the amino acid mutations needed for accurate determination of all variants of concern and variants of interest according to the definitions published by the U.S. Centers for Disease Control and Prevention. This protocol was able to amplify both nucleic acid targets into cDNA amplicons to be used as templates for Sanger sequencing on all 16 clinical specimens that were positive for SARS-CoV-2. View Full-Text
Keywords: Delta variant; variants of concern; variants of interest; SARS-CoV-2; spike protein; nested RT-PCR; Sanger sequencing; amino acid mutations; ACE2 RBD; N-terminal domain (NTD) Delta variant; variants of concern; variants of interest; SARS-CoV-2; spike protein; nested RT-PCR; Sanger sequencing; amino acid mutations; ACE2 RBD; N-terminal domain (NTD)
Show Figures

Figure 1

MDPI and ACS Style

Lee, S.H. A Routine Sanger Sequencing Target Specific Mutation Assay for SARS-CoV-2 Variants of Concern and Interest. Viruses 2021, 13, 2386. https://doi.org/10.3390/v13122386

AMA Style

Lee SH. A Routine Sanger Sequencing Target Specific Mutation Assay for SARS-CoV-2 Variants of Concern and Interest. Viruses. 2021; 13(12):2386. https://doi.org/10.3390/v13122386

Chicago/Turabian Style

Lee, Sin H. 2021. "A Routine Sanger Sequencing Target Specific Mutation Assay for SARS-CoV-2 Variants of Concern and Interest" Viruses 13, no. 12: 2386. https://doi.org/10.3390/v13122386

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop